ATS Reading List Podcast: Episode 2 - Treatment of Pulmonary Arterial Hypertension
In this episode, we have the pleasure of sitting down with Dr. Hilary DuBrock to discuss two foundational articles on pulmonary arterial hypertension treatment. We will discuss the 2013 SERAPHIN and 2015 AMBITION trials both published in the New England Journal of Medicine.
Show Notes
If you enjoyed this content, please follow or subscribe and leave us a review!
Access the ATS Reading List.
Recommended Reading
If you enjoyed this content, please follow or subscribe and leave us a review!
Access the ATS Reading List.
Recommended Reading
- Pulido T, Adzerikho I, Channick RN, et al. Macitentan and morbidity and mortality in pulmonary arterial hypertension. N Engl J Med. 2013;369(9):809-818.
- Supplement to: Pulido T et al. 2013.
- Galiè N, Barberà JA, Frost AE, et al. Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension. N Engl J Med. 2015;373(9):834-844. doi:10.1056/NEJMoa1413687
- Supplement to: Galiè et al. 2015.
- Simonneau G, Channick RN, Delcroix M, et al. Incident and prevalent cohorts with pulmonary arterial hypertension: insight from SERAPHIN. Eur Respir J. 2015;46(6):1711-1720. doi:10.1183/13993003.00364-2015
